Frank Rimerman Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Frank Rimerman Advisors's REGN Position: Q2 2026 in Review
Frank Rimerman Advisors reduced its Regeneron Pharmaceuticals (REGN) stake by 43% in Q2 2026, selling an estimated $294K and leaving 570 shares worth $355K. The position accounts for 0.02% of the portfolio, ranked #483.
Frank Rimerman Advisors first reported a position in REGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $776K in Q4 2025. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Frank Rimerman Advisors held 570 shares of Regeneron Pharmaceuticals worth $355K as of Q2 2026.
- Frank Rimerman Advisors sold 432 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $294K.
- Regeneron Pharmaceuticals made up 0.02% of Frank Rimerman Advisors's portfolio in Q2 2026, its #483 holding.
- Frank Rimerman Advisors first reported a position in Regeneron Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
- Frank Rimerman Advisors's Regeneron Pharmaceuticals position peaked at $776K in Q4 2025.
- 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Frank Rimerman Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.